drugset / Trial / NCT00846833

Haploidentical NK Cell Infusion in Malignant Melanoma

NCT00846833 ↗

Phase 1/2 Completed 12 enrolled Seoul National University Hospital
NaSingle-groupOpen-labelTreatment

Summary

We hypothesized that haploidentical NK cells kill tumor cells more efficiently than autologous NK cells, based on the missing-self hypothesis. Therefore, we performed this study to investigate the role of haploidentical NK cell therapy in patients with refractory or relapsed malignant melanoma.

Timeline

Start
2009-02
Primary completion
2011-02
Completion
2012-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Haploidentical NK cell Cell therapy — —

Indications